DRIVE WEALTH MANAGEMENT, LLC - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 21 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
DRIVE WEALTH MANAGEMENT, LLC ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q1 2023$55,352
-28.2%
34,380
-46.5%
0.02%
-41.0%
Q4 2022$77,044
-31.8%
64,203
-3.7%
0.04%
-63.6%
Q3 2022$113,000
+105.5%
66,6670.0%0.11%
+114.0%
Q2 2022$55,000
-24.7%
66,6670.0%0.05%
-19.4%
Q1 2022$73,000
-43.4%
66,6670.0%0.06%
-45.1%
Q4 2021$129,00066,6670.11%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q3 2023
NameSharesValueWeighting ↓
Mayo Clinic 181,754$161,8340.31%
PERKINS CAPITAL MANAGEMENT INC 150,000$1340.13%
Nantahala Capital Management 1,250,000$1,113,0000.10%
Princeton Global Asset Management LLC 16,833$14,9880.00%
MAI Capital Management 50,000$44,5200.00%
SG Americas Securities, LLC 50,453$450.00%
Walleye Capital LLC 225,956$201,1910.00%
UBS Group AG 108$960.00%
NewEdge Advisors, LLC 2,380$2,1190.00%
OSAIC HOLDINGS, INC. 700$6230.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders